Printer Friendly

Diagnosis of atopic dermatitis: from bedside to laboratory.

Clinical diagnosis of atopic dermatitis

The diagnosis of atopic dermatitis (AD) is often not straightforward, especially in adults. Young babies who present with typically dry pruritic dermatitis in the classic distribution according to the age of the child are easy to diagnose. [1] Several other conditions have to be considered in the differential diagnosis, as discussed below. Where the disease represents a mere continuation of AD since childhood, the diagnosis is usually easy and the clinical picture typical. With onset >18 years of age (adult-onset AD), the disease pattern is often not obvious, although it may still present with the usual flexural dermatitis seen in children. Non-typical morphological features and localisation are common with nummular, prurigo-like, follicular and seborrhoeic patterns that are often seen. [2] In adults, erythroderma is a rare manifestation of AD. [3] The physical and environmental factors for adults differ from those for children and are responsible for the different patterns of involvement.

The traditional criteria set out by Hanifrn and Rajka [4] are used less frequently than before. Williams et al. (UK Working Party) [5] developed a revised set of criteria, which was validated in the hospital setting [6] and in the community. [7] According to this group, these criteria should be adopted for the diagnosis of AD, even though a recent study [8] in children has shown that these criteria are not reliable when applied to low-prevalence populations, i.c. the amaXhosa in South Africa. The criteria are set out in Table 1.

The histological findings on skin biopsy may be suggestive of the diagnosis, but generally cannot be relied on to make the diagnosis. [5]

Total serum IgE levels are significantly raised in about 50% of cases and normal in the rest, reducing their value in the diagnosis. I he IgE level does not correlate with the severity of the dermatitis, and 15% of non-atopic individuals have raised IgE levels.

Several conditions have to be considered in the differential diagnosis of AD (Table 2). These have to be excluded clinically and by appropriate investigations.

Measuring the severity of atopic dermatitis

The severity of dermatitis can be measured and monitored in several ways. The SCORing Atopic Dermatitis (SCORAD) index, [9] the Objective Severity Assessment of Atopic Dermatitis (OSAAD) [10,13] and the Three Item Severity Score [14] all have merit in a research context, but are not practical for daily clinical use.

It is the opinion of the authors that the severity assessment should be simplified, with the objective to stratify treatment accordingly in individual patients. We propose:

* Measuring the area involved in percentage of body surface, where 1% body surface approximates the size of one of the patient s hands (including the fingers).

* Kstablishing acute, subacute or chronic changes, where acute changes would imply more severe dermatitis. [1]

* Determining the impact on the patients quality of life (e.g. sleep disturbances, absenteeism, visible scratch marks, social withdrawal).

Dermatitis can then be classified and treated as mild, moderate or severe as outlined below.

A flare of dermatitis can be defined as any episode of upgrading of the dermatitis, e.g. from mild to moderate (Table 3).

Special investigations

To diagnose AD, special investigations are rarely necessary, but may be performed mainly to identify trigger factors that flare up or aggravate the condition so that patients may be advised to avoid these. However, these investigations are useful in the management of AD, mostly in children. [15,16]

A skin biopsy is done occasionally and may be useful in an adult with generalised exfoliative erythroderma in order to differentiate it from other causes of erythroderma. [15]

Total serum IgE estimation, ImmunoCAP assays for specific IgE and skin-prick tests may be done to confirm the atopic nature of a patients condition.

The skin-prick test is the most common procedure used to confirm food and inhaled aeroallergen sensitisation. Either commercially available extracts or fresh foods may be used, mostly cows milk, hens egg, wheat, soy, fish and peanuts. Aeroallergens (mites, pollens, moulds, and animal dander) may be tested in the same way. Commercial extracts are placed directly on the skin, which is pricked through the liquid. Aqueous fresh foods (or solid native foods crushed with saline) may be tested similarly. Solid native foods such as fruit may also be tested by pricking the food with a lancet and then pricking the skin--the 'prick-prick test'. A new lancet should be used for each skin prick. The test site is observed for 15-20 minutes and the mean wheal reaction (largest diameter + 90[degrees] / 2) measured and recorded in millimetres. A positive control with histamine should be [greater than or equal to] 3 mm; a negative control with saline is also done. [17-20]

Variants of the skin-prick test include the scratch patch test, where the skin is scratched and the food applied under an occlusive patch, and the skin application test, where the food is applied to the skin without scratching and examined at 10-minute intervals for a reaction. These tests are not commonly used as they add no additional value to the routine test. [19,20]

Immediate-type (IgE-medialed) food allergy is diagnosed by taking a thorough history, performing tests, looking for specific IgE sensitisation by means of the tests mentioned above and performing oral food challenges if indicated. Negative skin and ImmunoCAP tests are useful for excluding an immediate-type reaction, but cannot exclude a delayed-type reaction.

Positive tests indicating sensitisation are not necessarily related to food allergy. The predictive values for a history of a food reaction, positive skin-prick test and positive food-specific IgE in isolation are poor for diagnosing food allergy in AD. The role of sensitisation must be interpreted together with the history, and in uncertain cases a food challenge test should be done to prove definite food allergy or food tolerance. If the diagnosis is not clear or the clinical relevance of a positive food allergy test is not certain, a food challenge lest should be performed. Specific methods for food challenge testing are available from the authors.

In adults with head and neck dermatitis a positive ImmunoCAP assay to Malassezia species may be useful, as such patients may benefit from treatment with oral anti-yeast treatment. [15,16]

Patch tests involve formal testing to diagnose superimposed allergic contact dermatitis, e.g. in adult patients with chronic hand dermatitis. The aetiology of the continuing dermatitis is elucidated. [15] Formal patch tests are also useful for deteriorating dermatitis that is being intensively treated, as the patient may have an allergic contact dermatitis to one of the components of the current topical treatment. [15]

The atopy patch lest is used to diagnose type IV hypersensitivity reactions and determine food and aeroallergen triggers for dermatitis. It is a specialised, time-consuming procedure that is highly specific, but with lower levels of sensitivity, [19] not often used in adults with AD. [15,16,18,19]

In cases of suspected immunodeficiency, tests such as human T-lymphotropic virus type 1 (HTLV-1), HIV, immunoglobulin subtypes, T- and B-cell numbers and functions will need to be done. If secondary bacterial infections are suspected, pus swabs will be necessary. A suspected herpes infection may be confirmed by a Tzanck smear, a rapid polymerase chain reaction test done on a dry swab or ciectronmicroscopy. [15]


[1.] Jordaan HF, Todd G, Sinclair W, Green R. Aetiopathogenesis of atopic dermatitis. S Afr Med J 2014; 104(10):706-709. []

[2.] Ozkaya E. Adult-onset atopic dermatitis. J Am Acad Dermatol 2005(52:579-582. [http://dx.doi. org/10.1016/j.jaad.2004.11.037]

[3.] Rym BM. Mourad M. Bechir Z. et al. Erythroderma in adults: A report of 80 cases. Int J Dermatol 2005; 44(9):731-735. []

[4.] Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 1980; 92:44-47.

[5.] Williams HC, Burney PG, Hay RJ. ct al. The UK Working Party's diagnostic criteria for atopic dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994; 131:383-396. []

[6.] Williams HC, Burney PG. Pembroke AC, Hay RJ. The UK Working Party's diagnostic criteria for atopic dermatitis. III. Independent hospital validation. Br I Dermatol 1994; 131:406-416. [http://dx.doi. org/10.1111/j.1365-2133.1994.tb08532.x|

[7.] Williams HC, Burney PG. Slrachan D. Hay RJ. Ihe UK Working Party's diagnostic criteria for atopic dermatitis. II. Observer variation of clinical diagnosis and signs of atopic dermatitis. Br J Dermatol 1994; 131:397-405. []

[8.] Chalmers DA, Todd G, Saxe N, et al. Validation of the UK Working Party diagnostic criteria for atopic eczema in a Xhosa-speaking African population. Br J Dermatol 2007; 156(1):111-116. [http://dx.doi. org/10.1111/j.1365-2133.2006.07606.x]

[9.] European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis. The SCORAD index: Consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1993; 186:23-31. []

[10.] Sugarman J, Fluhr J, Fowler A, et al. The Objective Severity Assessment Atopic Dermatitis score. Arch Dermatol 2003:139:1417-1422.

[11.] Angelova-Fischer I, Bauer A, Hipler UC, et al. The Objective Severity Assessment of Atopic Dermatitis (OSAAD) score: Validity, reliability and sensitivity in adult patients with atopic dermatitis. Br J Dermatol 2005:153:767-773. []

[12.] Frezzolini A, Paradisi M, Faffiro A, et al. Circulating interleukin-16 (Il-16) in children with atopic eczema/dermatitis syndrome (AEDS): A novel marker of disease activity. Acta Derm Vencreol 2002; 57:815-820.

[13.] Masuda K, Katoh N, Okuda F, Kishimoto S. Increased levels of serum interleukin -16 in adult type atopic dermatitis. Acta Derm Venereol 2003; 83:49-53. []

[14.] Charman CR, Venn Al, Williams UC. Measuring atopic eczema severity visually: Which variables are most important to patients? Arch Dermatol 2005; 141(9):1146-1151. []

[15.] Friedmann PS, Arden-Jones MR, Holden CA. Atopic dermatitis. In: Burns T, Breathnach S, Cox N, Griffiths C, eds. Rook's Textbook of Dermatology. 8th ed. Chichester, UK: Wiley Blackwell Publishers, 2010:24.27-24-28. []

[16.] Katsarou A, Armenaka MC. Atopic dermatitis in older patients: Particular points. J Eur Acad Dermatol Venereol 2011; 25(1): 12-18. []

[17.] Celakovska J, Ettlerova K, Ettler K. Vaneckova J. Egg allergy in patients over 14 years old suffering from atopic eczema. Int J Dermatol 2011; 50(7):811-818. []

[18.] Suh KY. Food allergy and atopic dermatitis: Separating fact from fiction. Semin Culan Med Surg 2010; 29(2):72-78. []

[19.] Celakovska J, Ettlerova K, Ettler K, Vaneckova J. Atopy patch test in diagnosis of food allergy to egg In adult patients suffering from atopic eczema. Three case reports. Acta Medica (Hradec Kralove) 2011; 54(1):29-35.

[20.] Bath-Hextall F, Delamere FM, Williams HC. Dietary exclusion fix improving established atopic eczema in adults and children: Systematic review. Allergy 2009; 64(2):258-264. []

W Sinclair, (1) MB ChB, MMed (Derm); J Aboobaker, (2) MB ChB, FFDerm (SA), FRCP (Lond), PhD; R J Green, (3) MB BCh, DCH, FCP (SA), DTM&H, MMed, FCCP, PhD, Dip Allergology (SA), DSc; M E Levin, (4) MB ChB, FCPacd (SA), Dip Allergology (SA), MMed (Paed), PhD, EEACI (UEMS), FAAAAI, FACAAI

(1) Department of Dermatology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa

(2) Department of Dermatology, University of KwaZulu-Natal, Durban, South Africa

(3) Department of Paediatrics and Child Health, Faculty of Health Sciences, University of Pretoria, South Africa

(4) Division of Asthma and Allergy, Department of Paediatrics, Faculty of Health Sciences, University of Cape Town and Red Cross War Memorial Childrens Hospital, Cape Town, South Africa

Corresponding author: W Sinclair (
Table 1. Revised criteria for the diagnosis of atopic dermatitis

Must have:


Plus three or more of the following:

  History of flexural dermatitis (front of elbows, back of knees,
  front of ankles, neck, around the eyes) or involvement of cheeks
  and/or extensor surfaces in children aged >18 months

  Visible flexural dermatitis involving the skin creases (or the
  cheeks and/or extensor surfaces in children aged >18 months)
  History of a dry skin in the past year

  History of asthma or hay fever (or atopic disease in a first-degree
  relative in children <4 years of age)

  Onset <2 years (for children aged >4 years at time of diagnosis)

Table 2. Differential diagnosis of atopic dermatitis

* Seborrhoeic dermatitis

* Discoid (nummular) dermatitis

* Irritant contact dermatitis (especially of the hands)

* Allergic contact dermatitis and airborne contact dermatitis

* Photo-allergic and photo-irritant dermatitis

* 'HIV dermatitis'

* Drug-induced dermatitis

* Cutaneous T-cell lymphoma

* Psoriasis, especially the erythrodermic type

* Scabies

* Insect bites

* Filariasis

Table 3. Assessment of the severity of atopic dermatitis

Mild: <5% body surface involved

  No acute changes

  No significant impact on quality of life

Moderate: 5-30% body surface involved

  Mild dermatitis with acute changes

  Mild dermatitis with significant impact on quality of life

Severe: >30% body surface involved

  Moderate dermatitis with acute changes

  Moderate dermatitis with significant impact on quality of life
COPYRIGHT 2014 South African Sports Medicine Association
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Author:Sinclair, W.; Aboobaker, J.; Green, R.J.; Levin, M.E.
Publication:South African Medical Journal
Article Type:Report
Geographic Code:4EUUK
Date:Oct 1, 2014
Previous Article:General approach to and summary of the guideline for the management of atopic dermatitis.
Next Article:Education and specialist referral of patients with atopic dermatitis.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters